These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23744005)

  • 1. Association of plasma des-acyl ghrelin levels with CKD.
    Gupta RK; Kuppusamy T; Patrie JT; Gaylinn B; Liu J; Thorner MO; Bolton WK
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1098-105. PubMed ID: 23744005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between FGF-23 and ghrelin levels in CKD patients: preliminary data.
    Ozturk S; Ozkan O; Efe M; Yazici H; Gursu M; Kaya AH; Cebeci E; Sumnu A; Karadag S; Poturoglu S; Kazancioglu R
    Minerva Urol Nefrol; 2016 Apr; 68(2):227-32. PubMed ID: 26125281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease.
    Naufel MF; Bordon M; de Aquino TM; Ribeiro EB; de Abreu Carvalhaes JT
    Pediatr Nephrol; 2010 Dec; 25(12):2477-82. PubMed ID: 20734087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there association between acyl-ghrelin and inflammation in hemodialysis patients?
    Barros Ade F; Moraes C; Pinto MB; Lobo JC; Mafra D
    J Bras Nefrol; 2013; 35(2):120-6. PubMed ID: 23812569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of Gastric Mucosal Atrophy Is the Major Determinant of Plasma Ghrelin Level in Hemodialysis Patients.
    Sakao Y; Sugimoto M; Ichikawa H; Sahara S; Tsuji T; Ohashi N; Kato A; Fujigaki Y; Sugimoto K; Furuta T; Sakao T; Yasuda H
    Am J Nephrol; 2016; 44(3):224-33. PubMed ID: 27578611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyl-ghrelin and obestatin plasma levels in different stages of chronic kidney disease.
    Borges N; Moraes C; Barros AF; Carraro-Eduardo JC; Fouque D; Mafra D
    J Ren Nutr; 2014 Mar; 24(2):100-4. PubMed ID: 24462497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin and ghrelin in chronic kidney disease: their associations with protein-energy wasting.
    Canpolat N; Sever L; Agbas A; Tasdemir M; Oruc C; Ekmekci OB; Caliskan S
    Pediatr Nephrol; 2018 Nov; 33(11):2113-2122. PubMed ID: 29980850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appetite-regulating hormones in chronic kidney disease patients.
    Oner-Iyidogan Y; Gurdol F; Kocak H; Oner P; Cetinalp-Demircan P; Caliskan Y; Kocak T; Turkmen A
    J Ren Nutr; 2011 Jul; 21(4):316-21. PubMed ID: 21193324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocytokines in Patients with Chronic Kidney Disease Stage 5.
    Yahya RS; Atwa MA; El-Sayed IH; El-Ghanaam DM; Hussein DT; El-Taweel FA
    Clin Lab; 2016; 62(1-2):21-30. PubMed ID: 27012030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease.
    Monzani A; Perrone M; Prodam F; Moia S; Genoni G; Testa S; Paglialonga F; Rapa A; Bona G; Montini G; Edefonti A
    Pediatr Nephrol; 2018 Apr; 33(4):661-672. PubMed ID: 29150712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute resistance exercise on acyl-ghrelin and obestatin levels in hemodialysis patients: a pilot study.
    Moraes C; Borges NA; Barboza J; Barros AF; Mafra D
    Ren Fail; 2015 Nov; 37(10):338-42. PubMed ID: 26381714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are ghrelin and leptin involved in food intake and body mass index in maintenance hemodialysis?
    Mafra D; Jolivot A; Chauveau P; Drai J; Azar R; Michel C; Fouque D
    J Ren Nutr; 2010 May; 20(3):151-7. PubMed ID: 19913442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease.
    Büscher AK; Büscher R; Hauffa BP; Hoyer PF
    Pediatr Nephrol; 2010 Nov; 25(11):2295-301. PubMed ID: 20607302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function.
    Duranton F; Lundin U; Gayrard N; Mischak H; Aparicio M; Mourad G; Daurès JP; Weinberger KM; Argilés A
    Clin J Am Soc Nephrol; 2014 Jan; 9(1):37-45. PubMed ID: 24235289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of markers of appetite and inflammation between hemodialysis patients with and without failed renal transplants.
    Caliskan Y; Yelken B; Gorgulu N; Ozkok A; Yazici H; Telci A; Turkmen A; Yildiz A; Sever MS
    J Ren Nutr; 2012 Mar; 22(2):258-267. PubMed ID: 22056149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin and leptin pathophysiology in chronic kidney disease.
    Gunta SS; Mak RH
    Pediatr Nephrol; 2013 Apr; 28(4):611-6. PubMed ID: 23229444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Among Metabolic Factors, Significance of Fasting and Postprandial Increases in Acyl and Desacyl Ghrelin and the Acyl/Desacyl Ratio in Obstructive Sleep Apnea before and after Treatment.
    Chihara Y; Akamizu T; Azuma M; Murase K; Harada Y; Tanizawa K; Handa T; Oga T; Mishima M; Chin K
    J Clin Sleep Med; 2015 Aug; 11(8):895-905. PubMed ID: 25845896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study.
    Rodriguez Ayala E; Pecoits-Filho R; Heimbürger O; Lindholm B; Nordfors L; Stenvinkel P
    Nephrol Dial Transplant; 2004 Feb; 19(2):421-6. PubMed ID: 14736968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
    Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum anion gap in adults with moderate chronic kidney disease increases risk for progression to end-stage renal disease.
    Banerjee T; Crews DC; Wesson DE; McCulloch CE; Johansen KL; Saydah S; Rios Burrows N; Saran R; Gillespie B; Bragg-Gresham J; Powe NR
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1244-F1253. PubMed ID: 30908932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.